NOVEL GALACTOSIDE INHIBITOR OF GALECTINS

The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns a...

Full description

Saved in:
Bibliographic Details
Main Authors ZETTERBERG, FREDRIK, NILSSON, ULF, BRIMERT, THOMAS, JOHNSSON, RICHARD, LEFFLER, HAKON, VERMA, PRIYA
Format Patent
LanguageEnglish
French
Published 21.07.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. La présente invention concerne un composé de formule générale (1). Le composé de formule (1) est conçu pour être utilisé dans une méthode de traitement d'un trouble associé à la liaison d'une galectine, par exemple la galectine-3 à un ligand chez un mammifère, notamment un être humain. En outre, la présente invention concerne une méthode pour le traitement d'un trouble associé à la liaison d'une galectine, par exemple la galectine-3 à un ligand chez un mammifère, notamment un être humain.
AbstractList The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. La présente invention concerne un composé de formule générale (1). Le composé de formule (1) est conçu pour être utilisé dans une méthode de traitement d'un trouble associé à la liaison d'une galectine, par exemple la galectine-3 à un ligand chez un mammifère, notamment un être humain. En outre, la présente invention concerne une méthode pour le traitement d'un trouble associé à la liaison d'une galectine, par exemple la galectine-3 à un ligand chez un mammifère, notamment un être humain.
Author JOHNSSON, RICHARD
VERMA, PRIYA
NILSSON, ULF
ZETTERBERG, FREDRIK
LEFFLER, HAKON
BRIMERT, THOMAS
Author_xml – fullname: ZETTERBERG, FREDRIK
– fullname: NILSSON, ULF
– fullname: BRIMERT, THOMAS
– fullname: JOHNSSON, RICHARD
– fullname: LEFFLER, HAKON
– fullname: VERMA, PRIYA
BookMark eNrjYmDJy89L5WTQ8PMPc_VRcHf0cXQO8Q_2dHFV8PTz8HTyDPEPUvB3A0m4Ood4-gXzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jA0MzQ0NjY2NTR0Nj4lQBAIOVJqo
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate NOUVEL INHIBITEUR GALACTOSIDE DE GALECTINES
ExternalDocumentID WO2016113335A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2016113335A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:04:26 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2016113335A13
Notes Application Number: WO2016EP50633
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160721&DB=EPODOC&CC=WO&NR=2016113335A1
ParticipantIDs epo_espacenet_WO2016113335A1
PublicationCentury 2000
PublicationDate 20160721
PublicationDateYYYYMMDD 2016-07-21
PublicationDate_xml – month: 07
  year: 2016
  text: 20160721
  day: 21
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies GALECTO BIOTECH AB
RelatedCompanies_xml – name: GALECTO BIOTECH AB
Score 3.0431118
Snippet The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Title NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160721&DB=EPODOC&locale=&CC=WO&NR=2016113335A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIJSfCm2aWv1YUibtrayNWPWubfRNBkIMoer-O97DZ3uaW9JDi4fcB-_S-4CcE08-SBnwjQsQRCguEQYhby3DS4EuhMl4VLlwgyyu-TVeZ64kxZ8rHJhVJ3QH1UcESWqRHmvlL5e_AexQvW2cnnL33Ho8zHOe6HeoOO6Whqx9DDoRUMWMqpTirhNz0aKZiEes10fsdIWOtJeLQ_ROKjzUhbrRiXeh-0h8ptXB9CS8w7s0tXfax3YGTRX3thspG95CDcZG0d97cnv-zRnL2kYaWmWpEGas5HG4poQ0Rzh-BFcxVFOEwOnnP7tcPrG1tdnH0Mbsb88Ac1xRCE8TgqPl45DOKoE10GNNDOFW5ilewrdTZzONpPPYa_u1qFKYnWhXX19ywu0sRW_VEfzC1KOe3A
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7GFOebTsXp1IJSfCmuWWv1YUiXtrbaNWPWubfRNBkIMoer-O97DZ3uaW8hB5cf8N3dl-QuAFfEkfdyJjqGKQgSFJsII5N3XYMLgeFETrhUuTCD5DZ8tZ4m9qQGH6tcGFUn9EcVR0RE5Yj3Qtnrxf8hlqfeVi5v-Dt2fT4Eac_TK3ZcVksjpu71e_6QeYzqlCJv05ORkpnIx7q2i1xpC4Nsp8SDP-6XeSmLdacS7MH2EPXNi32oyXkTGnT191oTdgbVlTc2K_QtD-A6YWM_1h7d2KUpe4k8X4uSMOpHKRtpLCgFPk2Rjh_CZeCnNDRwyOnfCqdvbH1-3SOoI_eXx6BZlsiEw0nm8NyyCEeTYFtokWYdYWed3G5Be5Omk83iC2iE6SCexlHyfAq7pag8tiRmG-rF17c8Q39b8HO1Tb9HhX5j
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+GALACTOSIDE+INHIBITOR+OF+GALECTINS&rft.inventor=ZETTERBERG%2C+FREDRIK&rft.inventor=NILSSON%2C+ULF&rft.inventor=BRIMERT%2C+THOMAS&rft.inventor=JOHNSSON%2C+RICHARD&rft.inventor=LEFFLER%2C+HAKON&rft.inventor=VERMA%2C+PRIYA&rft.date=2016-07-21&rft.externalDBID=A1&rft.externalDocID=WO2016113335A1